Norbert Health Closes $5M Seed II Funding


Norbert Health, a Brooklyn, NY-based contactless, multi-modal vital sign scanning company, closed a $5M seed II funding round.

The round, which brought total funding to $8M, was co-led by and HCVC with participation from Exor, C4 Ventures, LDV and Newlab.

The company intends to use the funds to grow the team, build additional features, pursue medical certification, and expand operations.

Led by CEO Alexandre Winter, and CPO Patrick Collins, Norbert Health has developed technologies that use smart sensing and data to allow people to understand what’s going on in their bodies. Its flagship product is an ambient scanner that can measure vital signs for anyone in a few seconds within a 6-ft range. The company’s wireless sensing technology uses radar to detect movement in people: from breathing to heartbeats and more.

Additional products in the pipeline will focus on delivering more medical grade vital signs and the potential to predict health outcomes based on subtle changes in data. Founded in 2019, the company is located in New York, San Francisco and Paris.